This report provides a comprehensive study of the global market for neurostimulation technologies and devices. It provides a detailed description of the different types of neurostimulation technologies and devices (invasive and noninvasive) and their current and historical market revenues.
Neurostimulation technologies and devices include spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, hypoglossal nerve stimulation, transcutaneous electrical nerve stimulation, transcranial magnetic stimulation and others.
This report also covers in detail the therapeutic applications of neurostimulation technologies and devices, including chronic pain, Parkinson’s disease, epilepsy, urinary and fecal incontinence, obstructive sleep apnea, essential tremor, obsessive compulsive disorder, major depressive disorder/clinical depression and others. An in-depth analysis of the global market for neurostimulation technologies and devices includes historical data and market projections by device type, therapeutic application and region.
Report Includes
- 51 tables
- An overview of the global markets and technologies for neurostimulation
- Estimation of the market size and analyses of market trends, with data from 2020 to 2022, estimates for 2023 and projection of CAGR through 2028
- Description of Dorsal Root Ganglion (DRG) neurostimulator system and discussion on approved indications of stimulation therapy for various diseases
- Detailed description of various types of stimulation such as spinal cord stimulation, transcutaneous electrical nerve stimulation, deep brain stimulation, sacral nerve stimulation, Vagus nerve stimulation, hypoglossal nerve stimulation, and transcranial magnetic stimulation; and discussion on their mode of action and advantages
- Information on recent therapy improvements and new indications for use, and discussion on alternatives to traditional stimulation therapies
- Coverage of ongoing scientific discoveries and technological advances in neurostimulation technologies and insights into marketed and pipeline (R&D) products, product recalls and reimbursement policies
- Market share analysis of neurostimulation devices by application, type and region, and evaluation of market size and forecast, and detailed analysis of drivers, challenges and opportunities affecting market growth
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Comprehensive company profiles of major players of the industry, including Axonics Inc., Boston Scientific Corp., Medtronic PLC, Synapse Biomedical Inc. and Xavant Technology
Table of Contents
Executive Summary
The human nervous system works as the chief commander of the human body. The medical science community has long believed that it has huge potential in treatment of human body disorders. Neurostimulation technology involves the alteration or modulation of nerves. Neurostimulation devices deliver electrical current or magnetic impulses directly to nerves in order to modify their activity.
Over the past 25 to 30 years, neurostimulation has emerged as one of the most dynamic fields of therapy, and has been actively investigated for treatment of a range of clinical conditions including chronic pain, movement disorders (Parkinson’s disease, tremor, dystonia and others), epilepsy, psychiatric disorders, functional restoration, cardiovascular disorders, gastrointestinal disorders and genitourinary disorders. It is also said to consist of “drug-free solutions.” Currently, the potential of neurostimulation technology is actively being explored for other clinical conditions including obesity, tinnitus and central nerve system disorders.
Given the vast size of the potential treatment population and the many ongoing scientific discoveries and technological advances in neurostimulation technologies, the market for neurostimulation devices market is poised for significant growth. Other factors expected to aid in the market boom include many countries’ growing elderly populations and increasing trends toward the use of nondrug therapies, greater expectations for quality of life, and improved patient attitudes toward receiving medical attention.
Neurostimulation technologies represent a cutting-edge field in neuroscience and medical science, aiming to modulate the activity of the nervous system to treat a wide range of neurological and neuropsychiatric disorders. These innovative techniques involve the application of electrical, magnetic or optogenetic stimuli to specific areas of the brain or nervous system, offering the potential to alleviate symptoms, restore lost function and enhance cognitive capabilities. Neurostimulation is based on the concept of neuromodulation, where electrical signals are applied to neurons to alter their activity and influence neural networks. Neurons communicate through electrical impulses, and by selectively stimulating or inhibiting specific neural populations, neuroscientists and clinicians can modulate brain function.
Companies Mentioned
- Abbott Laboratories
- Aleva Neurotherapeutics Sa
- Avery Biomedical Devices Inc.
- Axonics Inc.
- Bioinduction Ltd.
- Bioventus LLC
- Biowave Corp.
- Boston Scientific Corp.
- Brainsway Ltd.
- Cochlear Americas
- Cvrx Inc.
- Electrocore Inc.
- Inspire Medical Systems Inc.
- Integer Holdings Corp.
- Laborie Inc.
- Livanova plc
- Mag & More GmbH
- Magstim Inc.
- Medtronic plc
- Nalu Medical Inc.
- Neuromed Consulting Inc.
- Neurometrix Inc.
- Neuronetics Inc.
- Neuropace Inc.
- Neurosigma Inc.
- Neurovalens Ltd.
- Nevro Corp.
- Nexstim plc
- Nyxoah Sa
- Soterix Medical Inc.
- Synapse Biomedical Inc.
- Xavant Technology (Pty) Ltd.
- Zoll Medical Corp.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 160 |
| Published | September 2023 |
| Forecast Period | 2023 - 2028 |
| Estimated Market Value ( USD | $ 8.2 Billion |
| Forecasted Market Value ( USD | $ 11.7 Billion |
| Compound Annual Growth Rate | 7.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 33 |
